Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$479K Sell
3,724
-550
-13% -$64.4K 0.07% 101
2026
Q1
$514K Buy
4,274
+500
+13% +$57.7K 0.09% 87
2025
Q4
$397K Hold
3,774
0.07% 94
2025
Q3
$317K Sell
3,774
-350
-8% -$28.8K 0.05% 102
2025
Q2
$326K Hold
4,124
0.06% 98
2025
Q1
$370K Buy
+4,124
New +$385K 0.07% 89
2024
Q2
$449K Buy
3,624
+350
+11% +$45.1K 0.1% 82
2024
Q1
$432K Hold
3,274
0.1% 82
2023
Q4
$357K Sell
3,274
-350
-10% -$36.3K 0.09% 87
2023
Q3
$373K Hold
3,624
0.1% 83
2023
Q2
$418K Sell
3,624
-50
-1% -$5.68K 0.11% 82
2023
Q1
$391K Hold
3,674
0.11% 73
2022
Q4
$408K Hold
3,674
0.13% 69
2022
Q3
$316K Sell
3,674
-233
-6% -$20.8K 0.1% 68
2022
Q2
$356K Buy
3,907
+533
+16% +$47.3K 0.11% 68
2022
Q1
$277K Sell
3,374
-200
-6% -$15.8K 0.07% 74
2021
Q4
$274K Buy
+3,574
New +$285K 0.07% 73
2021
Q3
Sell
-1,874
Closed -$146K 201
2021
Q2
$146K Sell
1,874
-142
-7% -$10.6K 0.04% 87
2021
Q1
$148K Hold
2,016
0.05% 86
2020
Q4
$157K Buy
+2,016
New +$154K 0.06% 81
2020
Q3
Sell
-2,029
Closed -$150K 154
2020
Q2
$150K Buy
+2,029
New +$153K 0.06% 79
2019
Q1
Sell
-1,555
Closed -$113K 144
2018
Q4
$113K Buy
1,555
+7
+0.5% +$494 0.07% 73
2018
Q3
$105K Buy
1,548
+8
+0.5% +$510 0.06% 85
2018
Q2
$89K Hold
1,540
0.05% 89
2018
Q1
$80K Hold
1,540
0.05% 91
2017
Q4
$83K Hold
1,540
0.05% 95
2017
Q3
$94K Sell
1,540
-164
-10% -$9.94K 0.06% 87
2017
Q2
$104K Buy
1,704
+164
+11% +$9.98K 0.08% 86
2017
Q1
$93K Hold
1,540
0.07% 85
2016
Q4
$86K Buy
+1,540
New +$90.1K 0.07% 89

Other funds holding MRK

Perennial Advisors's MRK Position: Q2 2026 in Review

Perennial Advisors reduced its Merck (MRK) stake by 13% in Q2 2026, selling an estimated $64.4K and leaving 3,724 shares worth $479K. The position accounts for 0.07% of the portfolio, ranked #101.

Perennial Advisors first reported a position in MRK in Q4 2016 and has held it in 30 quarters since. The position peaked at $514K in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Perennial Advisors held 3,724 shares of Merck worth $479K as of Q2 2026.
  • Perennial Advisors sold 550 Merck shares in Q2 2026, an estimated $64.4K.
  • Merck made up 0.07% of Perennial Advisors's portfolio in Q2 2026, its #101 holding.
  • Perennial Advisors first reported a position in Merck in Q4 2016 and has held it in 30 quarters since.
  • Perennial Advisors's Merck position peaked at $514K in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Perennial Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.